[mattparmett]

That all makes sense. My question was more from a business logistics perspective - are you employing the counselors, or outsourcing to a third party? There is a lack of supply in that market and depending on growth, you may find it difficult to hire a large group of counselors. If you are outsourcing, be cognizant of who you are using as a vendor.

My fund's investment is in the genetic counseling space so I'm biased, but one of the issues to consider is using a lab-affiliated counseling group vs. truly independent counseling group. Another issue is, some counseling companies are focused on physician authorization (pre-test approvals to increase test volume) while others are focused on return of results, ongoing counseling etc. (the latter being more expensive).

Anyway, all things to think about. I also echo some of the other comments here around competing vs Invitae, Color, etc. They are all-in-one shops with scale and can be formidable - but also a potential exit opportunity if you've developed any unique/defensible IP.

Happy to chat more over email if you'd like.

[astroH]

At the moment, we are currently outsourcing genetic counseling. We simply don't have the capacity at the moment to bring that in-house. Very happy to discuss further over email ([e-mail]). One thing to consider is that for many of these other companies that are doing genotyping or panels, a lot of the analysis can be automated. For exome and genome testing, this is not currently the case and there is plenty of space to develop IP in that regard.